Baxter Considering Sale of Kidney Care Unit to Private Equity Investors
Monday, 4 March 2024, 19:07
Baxter Considering Sale of Kidney Care Unit to Private Equity Investors
Baxter (BAX) shares surged by 4% on Monday following reports that the company is exploring the sale of its kidney care business rather than spinning it out.
This strategic move could have significant implications for Baxter's future and shareholder value. The decision to opt for a sale to private equity investors speaks to the company's focus on enhancing shareholder returns.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.